Title Antitumor efficacy of oncolytic HSV-1 expressing cytosine deaminase is synergistically enhanced by DPD down-regulation and EMT inhibition in uveal melanoma xenograft
Authors Liu, Sisi
Zhang, Junwen
Fang, Sheng
Su, Xiaodong
Zhang, Qing
Zhu, Guidong
Zhu, Li
Zhao, Mingwei
Liu, Fusheng
Affiliation Peking Univ, Beijing Key Lab Diag & Therapy Retinal & Choroid, Peoples Hosp,Coll Optometry, Eye Dis & Optometry Inst,Hlth Sci Ctr,Dept Ophtha, Beijing, Peoples R China
Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Brain Tumor Res Ctr,Beijing Neurosurg Inst, Beijing, Peoples R China
Keywords HERPES-SIMPLEX-VIRUS
DIHYDROPYRIMIDINE DEHYDROGENASE
THYMIDYLATE SYNTHASE
THYMIDINE KINASE
CELL-LINES
CANCER
ACTIVATION
THERAPY
5-FLUOROCYTOSINE
5-FLUOROURACIL
Issue Date 28-Dec-2020
Publisher CANCER LETTERS
Abstract Uveal melanoma (UM) is the most common intraocular tumor in adults and has a high incidence of metastases. Possible treatments remain limited in UM with enucleation and radiation, leading to poor prognosis in this chemo-resistant carcinoma. Thus, urging demand for novel treatment is needed. We examined the antitumor efficacy of a new recombinant oncolytic herpes simplex virus type 1 (oHSV-1) armed with E.coli cytosine deaminase (CD). We determined the efficacy of the oncolytic virus in UM cell lines. In vivo experiments showed that oHSV-CD/5-fluorocytosine (5-FC) treatment reduce tumor volume and prolonged survival. We further demonstrated the molecular mechanisms of oHSV-CD/5-FC treatment. The oncolytic virus down-regulated IL-6 expression and thereby reversed the epithelial-mesenchymal transition (EMT) phenotype. Dihydropyrimidine dehydrogenase (DPD), the rate-limiting enzyme in 5-fluorouracil (5-FU) metabolism, was also down-regulated. Therefore, the efficacy of oHSV-CD/5-FC was synergistically enhanced by DPD down-regulation and EMT inhibition. This study provides solid evidence for the antitumor efficacy of oHSV-CD/5-FC treatment in vitro and in vivo. The molecular mechanisms of this treatment may bring a new therapeutic approach for future treatment of UM.
URI http://hdl.handle.net/20.500.11897/599561
ISSN 0304-3835
DOI 10.1016/j.canlet.2020.09.013
Indexed SCI(E)
Appears in Collections: 人民医院

Files in This Work
There are no files associated with this item.

Web of Science®


0

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.